What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

To investigate the roles of CXCL9 and CXCL10 in humoral response and T cell activity in COVID-19 patients with ARDS.

December 8, 2025Frontiers in ImmunologyOpen Access

CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells

View Full Paper

Ask AI

Bookmark

To investigate the roles of CXCL9 and CXCL10 in humoral response and T cell activity in COVID-19 patients with ARDS.
Analyzed 60 patients four months post-COVID-19, including 34 ARDS patients.
Measured anti-SARS-CoV-2 IgM/IgG levels and characterized B cell subsets.
Assessed cytokine and chemokine levels, and conducted in vitro assays on B cell activation.
IgG levels were significantly higher in ARDS patients compared to non-ARDS patients.
CXCL9 and CXCL10 levels positively correlated with IgG production.
In vitro, both chemokines enhanced plasma cell differentiation and IgG secretion.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Findings reveal CXCL9 and CXCL10's role in enhancing humoral responses and T cell activity in ARDS patients post COVID-19, indicating potential targets for therapy.

Cite This Study

Muñoz et al. (2025) studied this question.

synapsesocial.com/papers/693624a44fa91c937236c267 https://doi.org/10.3389/fimmu.2025.1684704

View Full Paper

Ask AI

Bookmark

Implication

Findings reveal CXCL9 and CXCL10's role in enhancing humoral responses and T cell activity in ARDS patients post COVID-19, indicating potential targets for therapy.

CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells

Key Points

Discussion

Implication

Cite This Study

CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading